See every side of every news story

Published 1 day ago • loading... • Updated 1 day ago

VYNE Therapeutics (NASDAQ:VYNE) Earns “Buy” Rating from HC Wainwright

Summary by americanbankingnews.com

VYNE Therapeutics (NASDAQ:VYNE – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports. They currently have a $5.75 price objective on the stock. HC Wainwright’s target price points to a potential upside of 112.96% from the company’s previous close. Separately, BTIG […]

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

All

Left

Center

Right

americanbankingnews.com

VYNE Therapeutics (NASDAQ:VYNE) Earns “Buy” Rating from HC Wainwright

VYNE Therapeutics (NASDAQ:VYNE – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports. They currently have a $5.75 price objective on the stock. HC Wainwright’s target price points to a potential upside of 112.96% from the company’s previous close. Separately, BTIG […]

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated23 hours agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

americanbankingnews.com broke the news in 1 day ago on Friday, February 21, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics